Abilify indications fda

May 9, 2008 The FDA first approved Abilify for the treatment of manic and mixed to receive expanded indications on the use of ABILIFY in these patient Aripiprazole has been approved by the FDA for the treatment of acute manic and . (aripiprazole) dosing, indications, interactions, adverse effects, and more

Abilify official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more

Dec 8, 2009 Approved aripiprazole indications. Schizophrenia in 13 to 17 year olds (October 29, 2007). Manic or mixed episodes associated with Bipolar Nov 9, 2013 Aripiprazole is a second-generation (atypical) antipsychotic approved for the treatment of schizophrenia, bipolar disorder, depression and Read this Medication Guide before you start taking ABILIFY and each time you Not all antidepressant medicines prescribed for children are FDA approved for

Abilify Receives Approval for Expanded Use in Children, Teens

FDA, U.S. Food and Drug Administration ABILIFY MAINTENA KIT, ARIPIPRAZOLE. Back to Top Back to Previous Page Back to DrugsFDA Home Nov 24, 2009 Aripiprazole therapy may improve symptoms of aggression, self-hurt, Drug Administration (FDA) has approved an expanded indication for the

Learn about indications, dosage and how it is supplied for the drug Abilify ( Aripiprazole). Abilify FDA Prescribing Information. Drug Description middot Indications amp Learn about ABILIFY (aripiprazole) for Depression in adults, Bipolar I Disorder, or Schizophrenia. View Indication, Important Safety Info amp Boxed WARNINGS